A randomised double blind parallel group study comparing 7 days of oral lamisil at a dose of 250 mg/day with placebo in tinea pedis

Authors: Evans E.G.V.; Anand C.; Craib L.; Sumner M.

Source: Journal of the European Academy of Dermatology and Venereology, Volume 9, Supplement 1, September 1997 , pp. 189-189(1)

Publisher: Elsevier

Language: English

Document Type: Abstract

DOI: 10.1016/S0926-9959(97)89626-2

Links for this article